AVGO: The Chart Gave Up, the Business Did Not

The chart says punishment: 35% off the 52-week high and 24 points behind the market over three to six months, an out-of-favor name in an out-of-favor sector. The business says accumulation: revenue growing about 24% a year, profit up 288% over the past year, returns on capital around 17% and improving, with most of that profit turning into real cash. The durability is concrete: a tight three-supplier oligopoly in AI accelerators, custom silicon design wins anchored by an Apple relationship extended through 2031, a VMware software base, and margins that hold steady even as the mix shifts. That steady margin is the tell of pricing power, and it is widening as the company grows. So the price leg and the business leg are simply telling different stories, and the gap between them is the whole read.

The market is pricing AVGO as if the AI order book were fragile, while the business is behaving as if it were scarce: one of only three credible homes for hyperscaler compute spend, converting 46% of revenue to free cash flow on minimal capex.

The honest bear case is real and leads here: semiconductors are cyclicals with brutal price erosion, and management itself warns that funding costs could slow the AI build-out, with customers whose capital is constrained able to defer or cancel orders. Concentration cuts the same wound: one customer is about 56% of revenue, Anthropic is on track to become the largest XPU customer, and the Apollo and Blackstone financing vehicles tie Broadcom's balance sheet to the labs' profitability. Add heavy stock-based comp diluting holders, tens of billions in long-term debt, net insider selling, and a momentum score of 1 out of 35, and the chart's punishment has a coherent story behind it. If the AI spend surge turns out to be a bubble, the business leg cracks with it.